Role of prebiotics, probiotics, and synbiotics in management of inflammatory bowel disease: Current perspectives

doi:10.3748/wjg.v29.i14.2078

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 29, Issue 14

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10599)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-6) series.

Item

Count

PDF

484

WORD

HTML

8256

Figures (1-6)

356

Tables (1-6)

451

Sum=9605

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

261

Download

733

Sum=994

Apr 14, 2023 (publication date) through Jul 24, 2024

Times Cited of This Article

Times Cited (51)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Apr 14, 2023; 29(14): 2078-2100
Published online Apr 14, 2023. doi: 10.3748/wjg.v29.i14.2078

Full Size Figure Download Figure

Figure 2 Role of dysbiosis in inflammatory bowel disease pathophysiology. SCFA: Short chain fatty acids; Tregs: Regulatory T cells; ROS: Reactive oxygen species.

Citation: Roy S, Dhaneshwar S. Role of prebiotics, probiotics, and synbiotics in management of inflammatory bowel disease: Current perspectives. World J Gastroenterol 2023; 29(14): 2078-2100
URL: https://www.wjgnet.com/1007-9327/full/v29/i14/2078.htm
DOI: https://dx.doi.org/10.3748/wjg.v29.i14.2078